China
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 54.90 B
|
Dec. 31, 2023 | USD 0.53 | 1.44% |
|
China |
|
2 |
USD 34.34 B
|
Dec. 31, 2023 | USD 0.52 | 6.79% |
|
China |
|
3 |
USD 8.45 B
|
Dec. 31, 2023 | USD 0.61 | 1.47% |
|
China |
|
4 |
USD 3.25 B
|
Dec. 31, 2023 | USD 1.71 | 1.65% |
|
China |
|
5 |
USD 3.04 B
|
Dec. 31, 2023 | USD 2.59 | 1.33% |
|
China |
|
6 |
USD 2.84 B
|
Dec. 31, 2023 | USD 0.25 | 2.80% |
|
China |
|
7 |
USD 1.35 B
|
Dec. 31, 2023 | USD 1.70 | 5.22% |
|
China |
|
8 |
USD 1.31 B
|
Dec. 31, 2023 | USD 1.58 | 1.46% |
|
China |
|
9 |
USD 1.26 B
|
Dec. 31, 2023 | USD 0.69 | 2.27% |
|
China |
|
10 |
USD 848.14 M
|
Dec. 31, 2023 | USD 1.17 | 1.53% |
|
China |
|
11 |
USD 799.15 M
|
Dec. 31, 2023 | USD 2.27 | 3.13% |
|
China |
|
12 |
USD 777.35 M
|
Dec. 31, 2023 | USD 1.47 | 2.19% |
|
China |
|
13 |
USD 726.21 M
|
Dec. 31, 2023 | USD 0.70 | 2.41% |
|
China |
|
14 |
USD 693.24 M
|
Dec. 31, 2023 | USD 2.26 | 4.12% |
|
China |
|
15 |
USD 690.67 M
|
Dec. 31, 2023 | USD 2.17 | 1.34% |
|
China |
|
16 |
USD 667.16 M
|
Dec. 31, 2023 | USD 1.93 | 2.10% |
|
China |
|
17 |
USD 622.24 M
|
Dec. 31, 2023 | USD 0.69 | 4.15% |
|
China |
|
18 |
USD 617.20 M
|
Dec. 31, 2023 | USD 32.18 | 1.97% |
|
China |
|
19 |
USD 586.79 M
|
Dec. 31, 2023 | USD 0.55 | 2.02% |
|
China |
|
20 |
USD 584.62 M
|
Dec. 31, 2023 | USD 1.73 | 3.02% |
|
China |
|
21 |
USD 543.39 M
|
Dec. 31, 2023 | USD 1.47 | 0.94% |
|
China |
|
22 |
USD 511.00 M
|
Dec. 31, 2023 | USD 1.34 | 4.35% |
|
China |
|
23 |
USD 510.29 M
|
Dec. 31, 2023 | USD 4.45 | 2.34% |
|
China |
|
24 |
USD 503.48 M
|
Dec. 31, 2023 | USD 1.49 | 3.42% |
|
China |
|
25 |
USD 494.23 M
|
Dec. 31, 2023 | USD 0.59 | 1.41% |
|
China |
|
26 |
USD 487.02 M
|
Dec. 31, 2023 | USD 7.28 | 2.32% |
|
China |
|
27 |
USD 485.40 M
|
Dec. 31, 2023 | USD 3.86 | 1.55% |
|
China |
|
28 |
USD 478.27 M
|
Dec. 31, 2023 | USD 6.95 | 4.11% |
|
China |
|
29 |
USD 477.37 M
|
Dec. 31, 2023 | USD 0.70 | 6.67% |
|
China |
|
30 |
USD 476.61 M
|
Dec. 31, 2023 | USD 0.74 | 1.21% |
|
China |
|
31 |
USD 457.23 M
|
Dec. 31, 2023 | USD 0.67 | 1.67% |
|
China |
|
32 |
USD 440.83 M
|
Dec. 31, 2023 | USD 1.46 | 3.48% |
|
China |
|
33 |
USD 425.30 M
|
Dec. 31, 2023 | USD 0.32 | 2.44% |
|
China |
|
34 |
USD 414.04 M
|
Dec. 31, 2023 | USD 5.92 | 1.98% |
|
China |
|
35 |
USD 405.62 M
|
Dec. 31, 2023 | USD 2.91 | 1.87% |
|
China |
|
36 |
USD 401.38 M
|
Dec. 31, 2023 | USD 0.61 | 2.08% |
|
China |
|
37 |
USD 393.30 M
|
Dec. 31, 2023 | USD 2.09 | 2.89% |
|
China |
|
38 |
USD 392.53 M
|
Dec. 31, 2023 | USD 2.19 | 4.03% |
|
China |
|
39 |
USD 390.02 M
|
Dec. 31, 2023 | USD 0.46 | 3.40% |
|
China |
|
40 |
USD 377.51 M
|
Dec. 31, 2023 | USD 1.08 | 2.47% |
|
China |
|
41 |
USD 376.14 M
|
Dec. 31, 2023 | USD 5.16 | 2.25% |
|
China |
|
42 |
USD 372.38 M
|
Dec. 31, 2023 | USD 2.59 | -10.24% |
|
China |
|
43 |
USD 364.70 M
|
Dec. 31, 2023 | USD 0.65 | 2.15% |
|
China |
|
44 |
USD 354.93 M
|
Dec. 31, 2023 | USD 0.31 | 4.14% |
|
China |
|
45 |
USD 347.28 M
|
Dec. 31, 2023 | USD 1.12 | 2.89% |
|
China |
|
46 |
USD 347.26 M
|
Dec. 31, 2023 | USD 1.32 | 0.63% |
|
China |
|
47 |
USD 340.85 M
|
Dec. 31, 2023 | USD 3.33 | 0.92% |
|
China |
|
48 |
USD 331.78 M
|
Dec. 31, 2023 | USD 4.77 | 5.76% |
|
China |
|
49 |
USD 330.71 M
|
Dec. 31, 2023 | USD 2.09 | 1.26% |
|
China |
|
50 |
USD 317.62 M
|
Dec. 31, 2023 | USD 3.66 | 2.21% |
|
China |
The Health Care company in China with the highest Total Non-Current Liabilities is Fosun International Limited (HKSE: 0656.HK) at USD 54.90 B.
The Health Care company in China with the lowest Total Non-Current Liabilities is Changchun BCHT Biotechnology Co. (Shanghai Stock Exchange: 688276.SS) at USD 162.54 K.
The top 10 Health Care companies in China by Total Non-Current Liabilities are Fosun International Limited, Hubei Biocause Pharmaceutical Co., Ltd., Genertec Universal Medical Group Company Limited, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Sinopharm Group Co. Ltd., Inner Mongolia Baotou Steel Union Co., Ltd., Pharmaron Beijing Co., Ltd., Shanghai Pharmaceuticals Holding Co., Ltd, MicroPort Scientific Corporation and Genscript Biotech Corporation.
The bottom 10 Health Care companies in China by Total Non-Current Liabilities are Changchun BCHT Biotechnology Co., Beijing Succeeder Technology Inc., Shanghai General Healthy Information and Technology Co., Ltd., HOB Biotech Group Corp.,Ltd, Touchstone International Medical Science Co., Ltd., Connect Biopharma Holdings Limited, Shanghai Allist Pharmaceuticals Co., Ltd., MicroTech Medical (Hangzhou) Co., Ltd., Shanghai Yizhong Pharmaceutical Co., Ltd. and Hubei Huarong Holding Co.,Ltd..